摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-[4-(4-Methoxy-phenyl)-piperazin-1-yl]-1-phenyl-pyrrolidine-2,5-dione

中文名称
——
中文别名
——
英文名称
3-[4-(4-Methoxy-phenyl)-piperazin-1-yl]-1-phenyl-pyrrolidine-2,5-dione
英文别名
3-[4-(4-Methoxyphenyl)piperazin-1-yl]-1-phenylpyrrolidine-2,5-dione
3-[4-(4-Methoxy-phenyl)-piperazin-1-yl]-1-phenyl-pyrrolidine-2,5-dione化学式
CAS
——
化学式
C21H23N3O3
mdl
——
分子量
365.432
InChiKey
KNZDJKLFFSHILE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    27
  • 可旋转键数:
    4
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    53.1
  • 氢给体数:
    0
  • 氢受体数:
    5

反应信息

  • 作为产物:
    参考文献:
    名称:
    In silico design and synthesis of piperazine-1-pyrrolidine-2,5-dione scaffold-based novel malic enzyme inhibitors
    摘要:
    Fragment-based virtual library design and virtual screening have been conducted against malic enzyme (ME) homology model. Several scaffolds have been identified as promising motifs to target ME's NADP binding site. One small focused library has been synthesized and tested against ME. Several compounds from this library have shown sub-micromolar inhibitory activity against malic enzyme. (c) 2005 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2005.10.065
点击查看最新优质反应信息

文献信息

  • In silico design and synthesis of piperazine-1-pyrrolidine-2,5-dione scaffold-based novel malic enzyme inhibitors
    作者:Y. John Zhang、Zhaolin Wang、Dennis Sprous、Roustem Nabioullin
    DOI:10.1016/j.bmcl.2005.10.065
    日期:2006.2
    Fragment-based virtual library design and virtual screening have been conducted against malic enzyme (ME) homology model. Several scaffolds have been identified as promising motifs to target ME's NADP binding site. One small focused library has been synthesized and tested against ME. Several compounds from this library have shown sub-micromolar inhibitory activity against malic enzyme. (c) 2005 Elsevier Ltd. All rights reserved.
查看更多